BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31469182)

  • 1. Sox9 Is a Modifier of the Liver Disease Severity in a Mouse Model of Alagille Syndrome.
    Adams JM; Huppert KA; Castro EC; Lopez MF; Niknejad N; Subramanian S; Zarrin-Khameh N; Finegold MJ; Huppert SS; Jafar-Nejad H
    Hepatology; 2020 Apr; 71(4):1331-1349. PubMed ID: 31469182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations.
    Andersson ER; Chivukula IV; Hankeova S; Sjöqvist M; Tsoi YL; Ramsköld D; Masek J; Elmansuri A; Hoogendoorn A; Vazquez E; Storvall H; Netušilová J; Huch M; Fischler B; Ellis E; Contreras A; Nemeth A; Chien KC; Clevers H; Sandberg R; Bryja V; Lendahl U
    Gastroenterology; 2018 Mar; 154(4):1080-1095. PubMed ID: 29162437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASO silencing of a glycosyltransferase, Poglut1 , improves the liver phenotypes in mouse models of Alagille syndrome.
    Niknejad N; Fox D; Burwinkel JL; Zarrin-Khameh N; Cho S; Soriano A; Cast AE; Lopez MF; Huppert KA; Rigo F; Huppert SS; Jafar-Nejad P; Jafar-Nejad H
    Hepatology; 2023 Nov; 78(5):1337-1351. PubMed ID: 37021797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regenerative failure of intrahepatic biliary cells in Alagille syndrome rescued by elevated Jagged/Notch/Sox9 signaling.
    Zhao C; Matalonga J; Lancman JJ; Liu L; Xiao C; Kumar S; Gates KP; He J; Graves A; Huisken J; Azuma M; Lu Z; Chen C; Ding BS; Dong PDS
    Proc Natl Acad Sci U S A; 2022 Dec; 119(50):e2201097119. PubMed ID: 36469766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotype.
    Ryan MJ; Bales C; Nelson A; Gonzalez DM; Underkoffler L; Segalov M; Wilson-Rawls J; Cole SE; Moran JL; Russo P; Spinner NB; Kusumi K; Loomes KM
    Hepatology; 2008 Dec; 48(6):1989-97. PubMed ID: 19026002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency.
    McCright B; Lozier J; Gridley T
    Development; 2002 Feb; 129(4):1075-82. PubMed ID: 11861489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premature senescence of the liver in Alagille patients.
    Jannone G; de Magnée C; Tambucci R; Evraerts J; Ravau J; Najimi M; Sokal EM
    PLoS One; 2023; 18(4):e0285019. PubMed ID: 37099537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray data reveal relationship between Jag1 and Ddr1 in mouse liver.
    Underkoffler LA; Carr E; Nelson A; Ryan MJ; Schulz R; Loomes KM
    PLoS One; 2013; 8(12):e84383. PubMed ID: 24391948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatially segregated defects and IGF1-responsiveness of hilar and peripheral biliary organoids from a model of Alagille syndrome.
    Iqbal A; Van Hul N; Belicova L; Corbat AA; Hankeova S; Andersson ER
    Liver Int; 2024 Feb; 44(2):541-558. PubMed ID: 38014627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Jagged 1 mutants cause liver defect in Alagille syndrome by overexpression of hepatocyte growth factor.
    Yuan ZR; Kobayashi N; Kohsaka T
    J Mol Biol; 2006 Feb; 356(3):559-68. PubMed ID: 16403414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic cholangiocyte regeneration from an Fgf-dependent extrahepatic progenitor niche in a zebrafish model of Alagille Syndrome.
    Zhao C; Lancman JJ; Yang Y; Gates KP; Cao D; Barske L; Matalonga J; Pan X; He J; Graves A; Huisken J; Chen C; Dong PDS
    Hepatology; 2022 Mar; 75(3):567-583. PubMed ID: 34569629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile duct proliferation in liver-specific Jag1 conditional knockout mice: effects of gene dosage.
    Loomes KM; Russo P; Ryan M; Nelson A; Underkoffler L; Glover C; Fu H; Gridley T; Kaestner KH; Oakey RJ
    Hepatology; 2007 Feb; 45(2):323-30. PubMed ID: 17366661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo formation of the biliary system by TGFβ-mediated hepatocyte transdifferentiation.
    Schaub JR; Huppert KA; Kurial SNT; Hsu BY; Cast AE; Donnelly B; Karns RA; Chen F; Rezvani M; Luu HY; Mattis AN; Rougemont AL; Rosenthal P; Huppert SS; Willenbring H
    Nature; 2018 May; 557(7704):247-251. PubMed ID: 29720662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile Ducts in Regenerative Liver Nodules of Alagille Patients Are Not the Result of Genetic Mosaicism.
    Rougemont AL; Alvarez F; McLin VA; Guiochon-Mantel A; Bouligand J; Clément S; Tonson La Tour A; Wildhaber BE; Rubbia-Brandt L; Sartelet H
    J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):91-3. PubMed ID: 25643021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch signaling regulates bile duct morphogenesis in mice.
    Lozier J; McCright B; Gridley T
    PLoS One; 2008 Mar; 3(3):e1851. PubMed ID: 18365007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jagged1 heterozygosity in mice results in a congenital cholangiopathy which is reversed by concomitant deletion of one copy of Poglut1 (Rumi).
    Thakurdas SM; Lopez MF; Kakuda S; Fernandez-Valdivia R; Zarrin-Khameh N; Haltiwanger RS; Jafar-Nejad H
    Hepatology; 2016 Feb; 63(2):550-65. PubMed ID: 26235536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome.
    Hofmann JJ; Zovein AC; Koh H; Radtke F; Weinmaster G; Iruela-Arispe ML
    Development; 2010 Dec; 137(23):4061-72. PubMed ID: 21062863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOTCH2 mutations in Alagille syndrome.
    Kamath BM; Bauer RC; Loomes KM; Chao G; Gerfen J; Hutchinson A; Hardikar W; Hirschfield G; Jara P; Krantz ID; Lapunzina P; Leonard L; Ling S; Ng VL; Hoang PL; Piccoli DA; Spinner NB
    J Med Genet; 2012 Feb; 49(2):138-44. PubMed ID: 22209762
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Tsai EA; Gilbert MA; Grochowski CM; Underkoffler LA; Meng H; Zhang X; Wang MM; Shitaye H; Hankenson KD; Piccoli D; Lin H; Kamath BM; Devoto M; Spinner NB; Loomes KM
    Cell Mol Gastroenterol Hepatol; 2016 Sep; 2(5):663-675.e2. PubMed ID: 28090565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic Novel Heterozygous Variant c.1076c>T p. (Ser359Phe) chr1: 120512166 in NOTCH2 Gene, Type 2 Alagille Syndrome Causing Neonatal Cholestasis: A Case Report.
    Uddin MS; Al Fulayyih S; Al Denaini FF; Al Hatlani MM
    Am J Case Rep; 2022 Oct; 23():e935840. PubMed ID: 36201396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.